6505--2027-2028 Influenza Virus Vaccine

The Department of Veterans Affairs (VA) is soliciting offers for pre‑filled, single‑dose influenza virus vaccine syringes (trivalent or quadrivalent) for the 2027‑2028 season. The contract will cover multiple line items targeting different patient populations (general ≥36 months, seniors ≥65 years, and pediatric 6 months‑35 months) and will be delivered to VA facilities, State Veteran Homes (Option 2), Bureau of Prisons, Indian Health Service sites, and the Captain James A. Lovell Federal Health Care Center. Quantities range from a few hundred to over 120 000 syringes per line item, with deliveries required in two shipments between mid‑August and mid‑October 2027. The award will be a firm‑fixed‑price, indefinite‑delivery/requirements contract for most items and a firm‑fixed‑price, definite‑quantity contract for two items. Offerors must be FDA‑approved manufacturers or have a manufacturer commitment, include a 0.5 % cost‑recovery fee, and comply with cGMP and bar‑coding requirements. • Product: Pre‑filled single‑dose influenza vaccine syringes (latex‑ and preservative‑free). • Quantities: Total ≈ 276 559 doses (≈ 27 656 boxes of 10). • Delivery windows: 1st shipment 08/15‑09/15 2027, 2nd shipment 09/16‑10/15 2027. • Contract type: Firm‑fixed‑price, IDR (lines 1‑7) and DFQ (lines 8‑9). • Award period: From award date through 03/14/2028. • Mandatory requirements: FDA approval, unique NDC per manufacturer, 0.5 % cost‑recovery fee, bar‑coding, reporting of orders and shipments. • Submission deadline: 09‑23‑2026 2:30 PM CT, electronic submission only. • Small‑business set‑aside information included; size standard 1 300 employees (NAICS 325412).